Search for: "In Interest of Ep" Results 421 - 440 of 1,007
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Oct 2019, 8:23 am by Simon Lester
The other interesting issue that this situation produces is: what can be considered a “solution” under the DSU? [read post]
16 Oct 2019, 12:36 pm by Site Admin
If you’re interested in attending our October 21st or October 29th seminar all around wills and trusts at Rider University, text the word INVITE to 609-554-5936. [read post]
10 Oct 2019, 7:35 am by Florian Mueller
Goulard, what the EP should never accept--for the sake of Europe's fitness for an increasingly digital future--is that one commissioner--and especially not a French commissioner--effectively controls both DG GROW (the Directorate-General for the Internal Market, previously called DG MARKT) and DG CONNECT (Directorate-General for Communications Networks, Content and Technology, previously called DG INFSOC = Information Society).Formally, the DGs are part of the Commission's… [read post]
9 Oct 2019, 10:24 am by Site Admin
If you’re interested in attending our October 21st or October 29th seminar all around wills and trusts at Rider University, text the word INVITE to 609-554-5936. [read post]
8 Oct 2019, 3:05 am by Liz Dunshee
Ann Lipton has some interesting perspectives on VC Slights’ distinction between business & legal compliance risks over on her Twitter feed. [read post]
30 Sep 2019, 3:26 am by Diane Tweedlie
The patent application in this case was refused for lack of novelty based on MPEG standards-related documentation cited in the search report. [read post]
28 Sep 2019, 7:53 am by Thorsten Bausch
European patent EP 1 613 394 had a single independent claim to a device for the desynchronization of activity of pathologically active brain areas. [read post]
13 Sep 2019, 4:07 am
The referral has already attracted a large number of amicus curiae from interested parties, including CIPA, EPI and AIPPI. [read post]
9 Sep 2019, 4:39 am by Miquel Montañá
The facts of the case may be summarized as follows: The complainant filed a patent infringement action against the defendant alleging infringement of patent EP 1.489.342 (“EP ‘342”). [read post]
2 Sep 2019, 5:26 am
Particularly, Mr Justice Arnold, following a CJEU ruling (IPKat post here), found that Truvada was not in fact protected by the EP patent because the patent only related to one of the drugs in Truvada. [read post]
30 Aug 2019, 2:25 pm by Silver Law Group
Silver Law Group represents the interests of investors who have been the victims of investment fraud. [read post]
26 Aug 2019, 10:04 pm by Robert Ambrogi
He had long had a passion for web-based media and a particular interest in podcasting and video, so moving to the Legal Talk Network was a natural fit. [read post]
23 Aug 2019, 4:29 pm by editor@howarddc.com
"  Instead, EPA states that it has decided to provide an opportunity to comment in this instance "because of the potential significant  interest from the public" and to be "completely transparent about these applications. [read post]
14 Aug 2019, 3:00 am by John Jenkins
By the numbers: The record buyback binge in 2018 accounted for almost half of stocks’ EPS growth, the highest share since 2007. [read post]
7 Aug 2019, 1:42 am
The dispute in Coloplast v Salts related to Coloplast's patent EP(UK) 2854723, and the alleged infringement of the patent by Salts, another ostomy product company. [read post]
2 Aug 2019, 7:32 am by Diane Tweedlie
The PCT application was filed within the 12 month priority period of P1 and some time after entry into the EP phase, the Applicant requested a correction of the priority claim under Rule 139 EPC. [read post]
1 Aug 2019, 2:14 am
Roche claimed that Entyvio infringed its European patent EP 2 007 809. [read post]